Last Updated: September 24, 2026

Details for Patent: 11,246,851

Name: Drug Patent Intelligence for US Patent 11246851
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 11,246,851 protect, and when does it expire?

Patent 11,246,851 protects LASIX ONYU and is included in one NDA.

This patent has five patent family members in five countries.

Summary for Patent: 11,246,851

Title:	Pharmaceutical compositions of furosemide and uses thereof
Abstract:	A pharmaceutical composition and a method of administering the pharmaceutical composition to a patient suffering from edema, heart failure, kidney or liver disease or having symptoms thereof are disclosed. The pharmaceutical composition includes furosemide, or a pharmaceutically acceptable salt, hydrate or ester thereof and a cyclodextrin.
Inventor(s):	Pieter Muntendam
Assignee:	SQ Innovation AG
Application Number:	US16/733,359
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 11,246,851

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sq Innovation	LASIX ONYU	furosemide	SOLUTION;SUBCUTANEOUS	217294-001	Oct 7, 2025		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial	Y			TREATMENT OF EDEMA IN ADULT PATIENTS WITH CHRONIC HEART FAILURE	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 11,246,851

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	3123718	⤷ Start Trial
China	113271923	⤷ Start Trial
European Patent Office	3906019	⤷ Start Trial
Spain	3058386	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2020141224	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.